Skip to main content
. Author manuscript; available in PMC: 2016 Feb 29.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775–782. doi: 10.1158/1055-9965.EPI-06-0168

Table 5.

Adjusted effects of swelling on quality of life: SF-12M, SF-12P, and FACT-B (results from longitudinal mixed modeling; N = 622)

Scale Estimate SE (95% confidence
limits)
P
SF-12M 1.67 0.39 (0.91,2.43) <0.01
  Mean scores at 3 y
   Not swelling 44.8 0.73
   Swelling 43.1 0.78
SF-12P 1.29 0.37 (0.56,2.03) <0.01
  Mean scores at 3 y
   Not swelling 49.8 0.84
   Swelling 48.6 0.88
FACT-B 2.19 0.67 (0.87,3.51) <0.01
  Mean scores at 3 y
   Not swelling 113.8 2.03
   Swelling 111.7 2.08

NOTE: Models adjusted for months past surgery (linear and quadratic term), age at diagnosis (in years), race (White versus other), marital status (married versus single), education (high school graduate or less, some college, college graduate), weight status category (time varying), current smoking status (time varying), weekly exercise category (time varying), having a child <8 y of age, employment status (full-time, part-time, homemaker, and other), reconstructive surgery, lumpectomy, mastectomy, nodal dissection (none, SND only, and AND), number of nodes removed, number of positive nodes, antibiotic use (time varying), radiation therapy, chemotherapy, and tamoxifen use (lag1 time varying).